nasal)

DRUG3 trials

Sponsors

Gentofte Hospital, Leids Universitair Medisch Centrum (LUMC)

Conditions

Influenzahealthy individuals

Phase 4

VAXXAIR TRIAL: In-depth Immunological Analysis of Airway Immunity following Nasal Live Attenuated and Intramuscular Influenza Vaccine A randomized controlled trial

RecruitingCTIS2023-506166-31-01

Gentofte HospitalInfluenza

Start: 2024-12-23Target: 55Updated: 2025-11-27

Antibody Glycosylation dynamics After Vaccination (AGAVE)

RecruitingCTIS2024-513981-21-00

Leids Universitair Medisch Centrum (LUMC)healthy individuals

Start: 2025-09-19Target: 60Updated: 2025-08-11

(The Lion Trial) LAIV induced Immune respOnse in the Nasopharynx

Active, not recruitingCTIS2024-513933-18-00

Leids Universitair Medisch Centrum (LUMC)Influenza

Start: 2025-09-18Target: 20Updated: 2025-07-24